Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia

Clinical proteomics of myeloid leukemia

(2010) Sigrun M Hjelle et al.   Genome Medicine

Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy

(2009) Praveen B. Gurpur et al.   AMERICAN JOURNAL OF PATHOLOGY

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia

(2009) Anne Margrete Øyan et al.   BMC CANCER

Targeted therapy in acute myeloid leukaemia: current status and future directions

(2009) Camilla Stapnes et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate

(2009) A Poggi et al.   LEUKEMIA

Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia

(2009) Marco Montillo et al.   LEUKEMIA RESEARCH

In vivobiological effects of ATRA in the treatment of AML

(2008) Anita Ryningen et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid

(2008) Anita Ryningen et al.   LEUKEMIA RESEARCH

Valproic Acid and All-Trans Retinoic Acid: Meta-Analysis of a Palliative Treatment Regimen in AML and MDS Patients

(2008) Frauke Bellos et al.   Oncology Research and Treatment